Healthcare -
Biotechnology - NASDAQ - US
$ 681.58
-1.68 %
$ 73.7 B
Market Cap
16.85
P/E
REGN - OPERATING INCOME
Operating Income REGN - Regeneron Pharmaceuticals, Inc.
4.05 B
LAST VALUE
-32.74%
2 YEAR CAGR
9.81%
5 YEAR CAGR
18.20%
10 YEAR CAGR